The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients
The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race
A Tsunami of Pills: Eli Lilly's Grand Plan to Conquer the Weight Loss Market
Crinetics' Game-Changing Oral Therapy, Palsonify, Secures FDA Approval for Acromegaly